Literature DB >> 5441162

Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.

V J Lotti, C C Porter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5441162

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  18 in total

1.  Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease.

Authors:  Lissa S Brod; Jason L Aldred; John G Nutt
Journal:  Mov Disord       Date:  2012-04-16       Impact factor: 10.338

2.  Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.

Authors:  T Oka; E Hosoya
Journal:  Psychopharmacology (Berl)       Date:  1976-06-23       Impact factor: 4.530

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  Central decarboxylation and uptake of L-DOPA.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Effects of L-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs.

Authors:  D H Minsker; A Scriabine; A L Stokes; C A Stone; M L Torchiana
Journal:  Experientia       Date:  1971-05-15

6.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

7.  The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats.

Authors:  P S Leppert; M Cortese; J A Fix
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

8.  Tyrosine loading enhances catecholamine excretion by rats.

Authors:  R Alonso; J C Agharanya; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

9.  Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse.

Authors:  B J Pleuvry; M A Tobias
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

10.  Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.

Authors:  D H Minsker; A L Stokes
Journal:  Experientia       Date:  1974-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.